Charles Gabbert1, Michael Donohue, John Arnold, Jeffrey B Schwimmer. 1. University of California, San Diego, Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, School of Medicine, and Department of Gastroenterology, Rady Children's Hospital San Diego, 200 West Arbor Dr, San Diego, CA 92103-8450, USA.
Abstract
OBJECTIVE: The primary aim of this study was to assess the relationship between adenovirus 36 (AD36)-specific antibodies and obesity in children. METHODS: A cross-sectional study of children 8 to 18 years of age was performed. Children were classified according to BMI percentile as nonobese (<95th percentile) or obese (≥95th percentile). The presence of AD36-specific neutralizing antibodies was assessed by using the serum neutralization assay. RESULTS: A total of 124 children (median age: 13.6 years) were studied. Of those children, 46% were nonobese and 54% were obese. AD36 positivity was present in 19 children (15%). The majority of children found to be AD36-positive were obese (15 [78%] of 19 children). AD36 positivity was significantly (P<.05) more frequent in obese children (15 [22%] of 67 children) than nonobese children (4 [7%] of 57 children). Among the subset of children who were obese, those who were AD36-positive had significantly larger anthropometric measures, including weight, BMI, waist circumference, and waist/height ratio. CONCLUSION: These data support an association of obesity and higher body weight with the presence of neutralizing antibodies to AD36 in children. If a cause-and-effect relationship is established, it would have considerable implications for the prevention and treatment of childhood obesity.
OBJECTIVE: The primary aim of this study was to assess the relationship between adenovirus 36 (AD36)-specific antibodies and obesity in children. METHODS: A cross-sectional study of children 8 to 18 years of age was performed. Children were classified according to BMI percentile as nonobese (<95th percentile) or obese (≥95th percentile). The presence of AD36-specific neutralizing antibodies was assessed by using the serum neutralization assay. RESULTS: A total of 124 children (median age: 13.6 years) were studied. Of those children, 46% were nonobese and 54% were obese. AD36 positivity was present in 19 children (15%). The majority of children found to be AD36-positive were obese (15 [78%] of 19 children). AD36 positivity was significantly (P<.05) more frequent in obesechildren (15 [22%] of 67 children) than nonobese children (4 [7%] of 57 children). Among the subset of children who were obese, those who were AD36-positive had significantly larger anthropometric measures, including weight, BMI, waist circumference, and waist/height ratio. CONCLUSION: These data support an association of obesity and higher body weight with the presence of neutralizing antibodies to AD36 in children. If a cause-and-effect relationship is established, it would have considerable implications for the prevention and treatment of childhood obesity.
Authors: E Ponterio; R Cangemi; S Mariani; G Casella; A De Cesare; F M Trovato; A Garozzo; L Gnessi Journal: Int J Obes (Lond) Date: 2015-08-21 Impact factor: 5.095
Authors: Cynthia L Chappell; Mary Dickerson; R Sue Day; Olga Dubuisson; Nikhil V Dhurandhar Journal: J Virol Methods Date: 2016-11-05 Impact factor: 2.014
Authors: Emma M Laing; Ralph A Tripp; Norman K Pollock; Clifton A Baile; Mary Anne Della-Fera; Srujana Rayalam; Stephen M Tompkins; Deborah A Keys; Richard D Lewis Journal: J Bone Miner Res Date: 2013-03 Impact factor: 6.741
Authors: P K Berger; N K Pollock; E M Laing; S J Warden; K M Hill Gallant; D B Hausman; R A Tripp; L D McCabe; G P McCabe; C M Weaver; M Peacock; R D Lewis Journal: J Clin Endocrinol Metab Date: 2014-06-13 Impact factor: 5.958
Authors: M A Sabin; D Burgner; R L Atkinson; Z Pei-Lun Lee; C G Magnussen; M Cheung; M Kähönen; T Lehtimäki; E Jokinen; T Laitinen; N Hutri-Kähönen; J S A Viikari; M Juonala; O T Raitakari Journal: Int J Obes (Lond) Date: 2015-06-09 Impact factor: 5.095
Authors: I Aldhoon-Hainerová; H Zamrazilová; R L Atkinson; L Dušátková; B Sedláčková; P Hlavatý; Z P Lee; M Kunešová; V Hainer Journal: Int J Obes (Lond) Date: 2013-05-14 Impact factor: 5.095